ImClone Systems NewsNews on ImClone Systems continually updated from thousands of sources around the net.Trade gap climbs with oil imports- September 17, 2008 The U.S. trade gap has hit a 16-month high, the job market is shrinking and exports - a rare item in the economy's plus column lately - might slow.http://www.topix.net/com/imcl/2008/09/trade-gap-climbs-with-oil-imports?fromrss=1 ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer- September 16, 2008 These data were presented today at the 33rd European Society for Medical Oncology Congress in Stockholm.http://www.topix.net/com/imcl/2008/09/imclone-provides-update-on-pivotal-phase-3-crystal-s... Ownership of Erbitux Follow-On Is Central to ImClone Takeover- September 15, 2008 The escalating squabble between Bristol-Myers Squibb and ImClone Systems over ownership of the potentially valuable Erbitux follow-on, IMC-11F8, is likely to be a big factor in determining whether a third party ...http://www.topix.net/com/imcl/2008/09/ownership-of-erbitux-follow-on-is-central-to-imclone... Public relations, press release distribution, investor relations, SEC filing- September 15, 2008 Fair Grounds Race Course & Slots has announced purses for its 137th season of Thoroughbred racing, which begins on Nov.http://www.topix.net/com/imcl/2008/09/public-relations-press-release-distribution-investor... Bristol-Meyers Squibb vs. Imclone: Icahn Stirs Up the Pot- September 14, 2008 I haven't mentioned the attempt by Bristol-Meyers Squibb to buy out Imclone until now.http://www.topix.net/com/imcl/2008/09/bristol-meyers-squibb-vs-imclone-icahn-stirs-up-the-... Big Pharma set for costly shopping spree- September 13, 2008 The existing drugs aren't working, so big pharmaceutical companies are set to step up the hunt for assets to buy in promising fields like biotechnology, as well as non-prescription areas of healthcare.http://www.topix.net/com/imcl/2008/09/big-pharma-set-for-costly-shopping-spree-2?fromrss=1 BMS Hopes for Further Buyout Discussions with ImClone- September 13, 2008 Bristol-Myers Squibb Co., in a letter to partner ImClone Systems Inc., showed no sign of backing down from its offer to buy ImClone for $60 per share, a bid that was rejected this week by a special committee of ...http://www.topix.net/com/imcl/2008/09/bms-hopes-for-further-buyout-discussions-with-imclon... Fitch Affirms Bristol-Myers Squibb Co.'s IDR at 'A+'; Outlook Stable- September 13, 2008 The Rating Outlook is Stable. The rating affirmation reflects sustained improvement in leverage after a significant rise in 2006 from generic competition to Pravachol and Plavix during the year.http://www.topix.net/com/imcl/2008/09/fitch-affirms-bristol-myers-squibb-co-s-idr-at-a-out... Health Winners & Losers: Bristol, ImClone- September 12, 2008 Biotech stocks made good water cooler talk Thursday as a few prospective merger stories opened to new chapters.http://www.topix.net/com/imcl/2008/09/health-winners-losers-bristol-imclone?fromrss=1 NYT, Lehman, Coke, WaMu are among big movers- September 12, 2008 Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market:NYSEThe New York Times Co., up $1.27 at $15.23Mexican financier Carlos Slim Helu and members of his family announced a 6.4 percent stake in the newspaper publisher.Lehman Brothers Holdings Inc., down $3.03 at $4.22The investment bank has approached other major financial institutions about taking a stake, in its fight to raise capital.Bristol-Myers Squibb Co., up 16 cents at $21.83http://www.topix.net/com/imcl/2008/09/nyt-lehman-coke-wamu-are-among-big-movers?fromrss=1 |